Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 2 | $44,476 |
| Sells | 43 | $225,205,533 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 20 Nov 2024 20:00 | BBIO | BridgeBio Pharma Inc | KUMAR NEIL | Chief Executive Officer | 19 Nov 2024 | Sale | 25,514 | 22.3856 | 571,146 | D |
| 20 Nov 2024 20:00 | BBIO | BridgeBio Pharma Inc | KUMAR NEIL | Chief Executive Officer | 19 Nov 2024 | Sale | 1,875 | 22.7625 | 42,680 | D |
| 20 Nov 2024 19:57 | BBIO | BridgeBio Pharma Inc | STEPHENSON BRIAN C | Secretary, Treasurer & CFO | 19 Nov 2024 | Sale | 4,156 | 22.4102 | 93,137 | D |
| 17 Sep 2024 18:44 | BBIO | BridgeBio Pharma Inc | KKR GENETIC DISORDER L.P. | 10% | 13 Sep 2024 | Sale | 5,800,000 | 25.75 | 149,350,000 | I |
| 20 Aug 2024 18:31 | BBIO | BridgeBio Pharma Inc | KUMAR NEIL | Chief Executive Officer | 19 Aug 2024 | Sale | 11,197 | 25.1288 | 281,367 | D |
| 20 Aug 2024 18:31 | BBIO | BridgeBio Pharma Inc | KUMAR NEIL | Chief Executive Officer | 19 Aug 2024 | Sale | 16,192 | 24.3879 | 394,889 | D |
| 20 Aug 2024 18:27 | BBIO | BridgeBio Pharma Inc | STEPHENSON BRIAN C | Secretary, Treasurer & CFO | 19 Aug 2024 | Sale | 1,698 | 25.1288 | 42,669 | D |
| 20 Aug 2024 18:27 | BBIO | BridgeBio Pharma Inc | STEPHENSON BRIAN C | Secretary, Treasurer & CFO | 19 Aug 2024 | Sale | 2,457 | 24.3878 | 59,921 | D |
| 05 Jun 2024 16:53 | BBIO | BridgeBio Pharma Inc | SCOTT RANDAL W. | Director | 04 Jun 2024 | Sale | 1,500 | 31.3 | 46,950 | I |
| 05 Jun 2024 16:53 | BBIO | BridgeBio Pharma Inc | SCOTT RANDAL W. | Director | 03 Jun 2024 | Sale | 200 | 29.475 | 5,895 | I |
| 05 Jun 2024 16:53 | BBIO | BridgeBio Pharma Inc | SCOTT RANDAL W. | Director | 03 Jun 2024 | Sale | 800 | 28.6844 | 22,948 | I |
| 05 Mar 2024 16:00 | BBIO | BridgeBio Pharma Inc | SCOTT RANDAL W. | Director | 01 Mar 2024 | Sale | 2,500 | 34 | 85,000 | I |
| 20 Feb 2024 16:03 | BBIO | BridgeBio Pharma Inc | VALANTINE HANNAH | Director | 15 Feb 2024 | Sale | 2,915 | 37.75 | 110,041 | D |
| 13 Feb 2024 16:00 | BBIO | BridgeBio Pharma Inc | VALANTINE HANNAH | Director | 28 Dec 2021 | Purchase | 1,891 | 13.18 | 24,923 | I |
| 13 Feb 2024 16:00 | BBIO | BridgeBio Pharma Inc | VALANTINE HANNAH | Director | 28 Dec 2021 | Purchase | 1,542 | 12.68 | 19,553 | I |
| 18 Jan 2024 16:10 | BBIO | BridgeBio Pharma Inc | VALANTINE HANNAH | Director | 16 Jan 2024 | Sale | 2,915 | 37.97 | 110,683 | D |
| 28 Dec 2023 16:00 | BBIO | BridgeBio Pharma Inc | MCCORMICK FRANK | Director | 26 Dec 2023 | Sale | 100,000 | 42.06 | 4,206,000 | I |
| 20 Dec 2023 16:00 | BBIO | BridgeBio Pharma Inc | SCOTT RANDAL W. | Director | 18 Dec 2023 | Sale | 2,000 | 40 | 80,000 | I |
| 19 Dec 2023 16:00 | BBIO | BridgeBio Pharma Inc | VALANTINE HANNAH | Director | 15 Dec 2023 | Sale | 2,915 | 36.12 | 105,290 | D |
| 05 Dec 2023 16:00 | BBIO | BridgeBio Pharma Inc | SCOTT RANDAL W. | Director | 01 Dec 2023 | Sale | 1,500 | 30 | 45,000 | I |
| 05 Dec 2023 16:00 | BBIO | BridgeBio Pharma Inc | SCOTT RANDAL W. | Director | 01 Dec 2023 | Sale | 1,000 | 28.5 | 28,500 | I |
| 20 Nov 2023 16:00 | BBIO | BridgeBio Pharma Inc | STEPHENSON BRIAN C | Secretary, Treasurer & CFO | 17 Nov 2023 | Sale | 22,685 | 29.0967 | 660,059 | D |
| 20 Nov 2023 16:00 | BBIO | BridgeBio Pharma Inc | KUMAR NEIL | CEO and President | 17 Nov 2023 | Sale | 200 | 29.55 | 5,910 | D |
| 20 Nov 2023 16:00 | BBIO | BridgeBio Pharma Inc | KUMAR NEIL | CEO and President | 17 Nov 2023 | Sale | 51,352 | 29.0958 | 1,494,128 | D |
| 17 Nov 2023 16:09 | BBIO | BridgeBio Pharma Inc | VALANTINE HANNAH | Director | 15 Nov 2023 | Sale | 2,915 | 30 | 87,450 | D |
| 07 Sep 2023 16:00 | BBIO | BridgeBio Pharma Inc | SCOTT RANDAL W. | Director | 05 Sep 2023 | Sale | 2,500 | 30 | 75,000 | I |
| 18 Aug 2023 16:00 | BBIO | BridgeBio Pharma Inc | STEPHENSON BRIAN C | Secretary, Treasurer & CFO | 17 Aug 2023 | Sale | 22,683 | 28.5877 | 648,455 | D |
| 18 Aug 2023 16:00 | BBIO | BridgeBio Pharma Inc | KUMAR NEIL | CEO and President | 17 Aug 2023 | Sale | 51,552 | 28.5883 | 1,473,784 | D |
| 19 Jul 2023 21:33 | BBIO | BridgeBio Pharma Inc | VIKING GLOBAL INVESTORS LP | 10% | 18 Jul 2023 | Sale | 1,500,000 | 35 | 52,500,000 | I |
| 18 May 2023 16:07 | BBIO | BridgeBio Pharma Inc | KUMAR NEIL | CEO and President | 17 May 2023 | Sale | 51,552 | 14.0095 | 722,218 | D |
| 18 May 2023 16:02 | BBIO | BridgeBio Pharma Inc | STEPHENSON BRIAN C | Secretary, Treasurer & CFO | 17 May 2023 | Sale | 24,424 | 14.0095 | 342,168 | D |
| 05 May 2023 16:03 | BBIO | BridgeBio Pharma Inc | KUMAR NEIL | CEO and President | 03 May 2023 | Sale | 120,000 | 14.1812 | 1,701,744 | I |
| 05 May 2023 16:01 | BBIO | BridgeBio Pharma Inc | STEPHENSON BRIAN C | Secretary, Treasurer & CFO | 03 May 2023 | Sale | 64,929 | 14.18 | 920,693 | D |
| 07 Apr 2023 16:42 | BBIO | BridgeBio Pharma Inc | STEPHENSON BRIAN C | Secretary, Treasurer & CFO | 05 Apr 2023 | Sale | 55,500 | 15.454 | 857,697 | D |
| 07 Apr 2023 16:39 | BBIO | BridgeBio Pharma Inc | KUMAR NEIL | CEO and President | 05 Apr 2023 | Sale | 120,000 | 15.4638 | 1,855,656 | I |
| 03 Mar 2023 20:04 | BBIO | BridgeBio Pharma Inc | STEPHENSON BRIAN C | Secretary, Treasurer & CFO | 03 Mar 2023 | Sale | 62,692 | 10.9607 | 687,148 | D |
| 03 Mar 2023 20:01 | BBIO | BridgeBio Pharma Inc | KUMAR NEIL | CEO and President | 03 Mar 2023 | Sale | 120,000 | 10.9602 | 1,315,224 | I |
| 21 Feb 2023 20:16 | BBIO | BridgeBio Pharma Inc | STEPHENSON BRIAN C | Secretary, Treasurer & CFO | 17 Feb 2023 | Sale | 2,150 | 13.0646 | 28,089 | D |
| 21 Feb 2023 20:16 | BBIO | BridgeBio Pharma Inc | STEPHENSON BRIAN C | Secretary, Treasurer & CFO | 17 Feb 2023 | Sale | 15,567 | 12.6535 | 196,977 | D |
| 21 Feb 2023 20:12 | BBIO | BridgeBio Pharma Inc | KUMAR NEIL | CEO and President | 17 Feb 2023 | Sale | 44,798 | 12.7031 | 569,073 | D |
| 06 Feb 2023 19:43 | BBIO | BridgeBio Pharma Inc | STEPHENSON BRIAN C | Secretary, Treasurer & CFO | 03 Feb 2023 | Sale | 61,040 | 11.0079 | 671,922 | D |
| 06 Feb 2023 19:26 | BBIO | BridgeBio Pharma Inc | KUMAR NEIL | CEO and President | 03 Feb 2023 | Sale | 120,000 | 11.0058 | 1,320,696 | I |
| 06 Jan 2023 20:38 | BBIO | BridgeBio Pharma Inc | STEPHENSON BRIAN C | Secretary, Treasurer & CFO | 05 Jan 2023 | Sale | 61,040 | 7.6748 | 468,470 | D |
| 06 Jan 2023 20:35 | BBIO | BridgeBio Pharma Inc | KUMAR NEIL | CEO and President | 05 Jan 2023 | Sale | 120,000 | 7.6738 | 920,856 | I |
| 21 Dec 2022 19:58 | BBIO | BridgeBio Pharma Inc | KUMAR NEIL | CEO and President | 21 Dec 2022 | Sale | 200,000 | 0 | 0 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)